CIDRAP newsletters options
During a 4-day pause of fighting in an ongoing conflict, 306,000 Yemenis, including 164,000 children under the age of 15, were vaccinated with the cholera vaccine, according to an update today from the World Health Organization (WHO).
In new developments, an attack in Butembo injured burial team members, and a rights group called for the International Criminal Court to expand its probe into Beni attacks as outbreak cases reach 165.
Fifty-seven people have fallen ill with salmonellosis, while Listeria has caused 1 death.
The results of a small clinical trial in France show that a topical treatment containing a cocktail of bacteriophages successfully reduced bacterial burden in patients with infected burn wounds, but at a significantly slower rate than standard of care. The findings appeared yesterday in The Lancet Infectious Diseases.
The Saudi Arabian Ministry of Health (MOH) today recorded a new case of MERS-CoV for epidemiologic week 40, which is this week.
A 49-year-old man from Najran was diagnosed as having MERS-CoV (Middle East respiratory syndrome coronavirus). The MOH said the man was hospitalized and likely exposed to the virus in a community setting. He had not reported recent contact with camels, a known risk factor.
Temperature probes increased the risk of infection nearly 7 times.
Of 32 Saudi MERS cases over the summer, 12 were part of illness clusters.
Massachusetts General Hospital (MGH) said today it was part of an international multisite study evaluating ZMapp, an experimental Ebola treatment. ZMapp contains three antibodies and is being used in the current outbreak in the Democratic Republic of the Congo (DRC)
Both newly reported patients belonged to families that refused Ebola vaccination, and one of them died.
As the Southern Hemisphere's flu season winds down, disease levels in temperate South American and southern Africa countries decreased or have peaked in recent weeks, according to the latest global flu update from the World Health Organization (WHO).
The results of a phase 3 randomized, controlled clinical trial show that monotherapy with the antibiotic/beta-lacatamase inhibitor combination Vabomere (meropenem-vaborbactam) in patients with carbapenem-resistant Enterobacteriaceae (CRE) infections was associated with increased clinical cure, decreased mortality, and reduced kidney toxicity compared with the best available therapy (BAT).
The outbreak grows to 159 cases, 127 of them confirmed, and 104 deaths.
The Saudi Arabian Ministry of Health (MOH) noted two more MERS-CoV cases in epidemiologic week 39 (last week) and one in epidemiologic week 38, and two of the cases proved fatal.
Researchers from the Cleveland Clinic have observed that telemedicine encounters in which antibiotics were prescribed for a respiratory tract infection (RTI) were shorter than encounters where a non-antibiotic or nothing were prescribed.
There are now 155 cases (124 confirmed, 31 probable), including 102 deaths, in the outbreak.
Research on the device indicates it has the potential to provide quick, low-cost diagnostics.
The experts also called for 3 new pandemic candidate vaccine viruses.
A new study examining racial and ethnic disparities in antimicrobial drug use in the United States shows that white people filled twice as many antibiotic drug prescriptions per capita compared with people of other races and ethnicities. The study was published yesterday in Emerging Infectious Diseases.
The Coalition for Epidemic Preparedness Innovations (CEPI) yesterday announced that it has awarded a contract worth as much as $19 million to Oxford University and Janssen Vaccines to advance the development and manufacture of a vaccine against MERS-CoV and do preclinical studies of new vaccines against Lassa and Nipah viruses.
